961 related articles for article (PubMed ID: 23228259)
21. The effect of IL-17 on the production of proinflammatory cytokines and matrix metalloproteinase-1 by human periodontal ligament fibroblasts.
Shibata M; Shintaku Y; Matsuzaki K; Uematsu S
Orthod Craniofac Res; 2014 Feb; 17(1):60-8. PubMed ID: 25125133
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase inhibitors reduce collagen gel contraction and alpha-smooth muscle actin expression by periodontal ligament cells.
Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW
J Periodontal Res; 2009 Apr; 44(2):266-74. PubMed ID: 18973523
[TBL] [Abstract][Full Text] [Related]
23. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
[TBL] [Abstract][Full Text] [Related]
24. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
25. Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation.
Attia M; Huet E; Gossard C; Menashi S; Tassoni MC; Martelly I
Am J Sports Med; 2013 Apr; 41(4):908-17. PubMed ID: 23404084
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
27. Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein.
Aust G; Hofmann A; Laue S; Rost A; Köhler T; Scherbaum WA
Thyroid; 1997 Oct; 7(5):713-24. PubMed ID: 9349574
[TBL] [Abstract][Full Text] [Related]
28. Growth factor effects on the expression of collagenase and TIMP-1 in periodontal ligament cells.
Alvares O; Klebe R; Grant G; Cochran DL
J Periodontol; 1995 Jul; 66(7):552-8. PubMed ID: 7562346
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts: the role of protein kinase C.
Domeij H; Modéer T; Yucel-Lindberg T
J Periodontal Res; 2004 Oct; 39(5):308-14. PubMed ID: 15324351
[TBL] [Abstract][Full Text] [Related]
30. Role of fibroblast growth factor-2 in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human intestinal myofibroblasts.
Yasui H; Andoh A; Bamba S; Inatomi O; Ishida H; Fujiyama Y
Digestion; 2004; 69(1):34-44. PubMed ID: 14755151
[TBL] [Abstract][Full Text] [Related]
31. Effects of interleukin-1 beta on matrix metalloproteinase-3 levels in human periodontal ligament cells.
Nakaya H; Oates TW; Hoang AM; Kamoi K; Cochran DL
J Periodontol; 1997 Jun; 68(6):517-23. PubMed ID: 9203094
[TBL] [Abstract][Full Text] [Related]
32. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
[TBL] [Abstract][Full Text] [Related]
33. Hydrocortisone affects the expression of matrix metalloproteinases (MMP-1, -2, -3, -7, and -11) and tissue inhibitor of matrix metalloproteinases (TIMP-1) in human gingival fibroblasts.
Cury PR; Araújo VC; Canavez F; Furuse C; Araújo NS
J Periodontol; 2007 Jul; 78(7):1309-15. PubMed ID: 17608586
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases MMP-2, -9 and tissue inhibitors TIMP-1, -2 expression and secretion by primary human osteoblast cells in response to titanium, zirconia, and alumina ceramics.
Oum'hamed Z; Garnotel R; Josset Y; Trenteseaux C; Laurent-Maquin D
J Biomed Mater Res A; 2004 Jan; 68(1):114-22. PubMed ID: 14661256
[TBL] [Abstract][Full Text] [Related]
35. Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium.
Braundmeier AG; Fazleabas AT; Lessey BA; Guo H; Toole BP; Nowak RA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2358-65. PubMed ID: 16522689
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase-3 secretion from human pancreatic periacinar myofibroblasts in response to inflammatory mediators.
Inatomi O; Andoh A; Yagi Y; Ogawa A; Hata K; Shiomi H; Tani T; Takayanagi A; Shimizu N; Fujiyama Y
Pancreas; 2007 Jan; 34(1):126-32. PubMed ID: 17198194
[TBL] [Abstract][Full Text] [Related]
37. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Xu Q; Ohara N; Liu J; Amano M; Sitruk-Ware R; Yoshida S; Maruo T
Mol Hum Reprod; 2008 Mar; 14(3):181-91. PubMed ID: 18216291
[TBL] [Abstract][Full Text] [Related]
38. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
[TBL] [Abstract][Full Text] [Related]
39. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
[TBL] [Abstract][Full Text] [Related]
40. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
